Has Jeffrey Deitch, DO received payments from drug or device companies?

Yes. Drug and device makers reported $220,367 in general payments to Jeffrey Deitch, DO across 1,027 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Deitch, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Deitch, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Deitch, DO

Family Medicine · Sterling Heights, MINPI 1386634749

Payments from drug & device makers

$220,367in general payments, 2019–2025

Across 1,027 payments — averaging $214.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sun Pharmaceutical Industries Inc.$37K
Otsuka America Pharmaceutical, Inc.$34K
Teva Pharmaceuticals USA, Inc.$31K
Johnson & Johnson$28K
Sunovion Pharmaceuticals Inc.$26K
Urovant Sciences Inc$19K
plus $46K from 45 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sun Pharmaceutical Industries Inc.	63	$36,501
Otsuka America Pharmaceutical, Inc.	66	$34,099
Teva Pharmaceuticals USA, Inc.	46	$30,541
Johnson & Johnson	44	$27,844
Sunovion Pharmaceuticals Inc.	88	$26,249
Urovant Sciences Inc	43	$18,943
Novo Nordisk AS	6	$13,600
Sumitomo Pharma America, Inc.	36	$13,304
Sanofi US Services Inc.	1	$10,000
Novo Nordisk	206	$1,913
Amgen	65	$1,153
Boehringer Ingelheim	39	$805
Pfizer	51	$755
AbbVie(2 entities)	44	$670
Lilly USA, LLC	45	$615
AstraZeneca	21	$401
Novartis	25	$400
Astellas Pharma US Inc	10	$272
GSK	18	$247
Amarin Pharma, Inc.	14	$226
Esperion Therapeutics, Inc.	10	$181
Dexcom, Inc.	9	$181
Avanir Pharmaceuticals, Inc.	2	$139
Lundbeck LLC	6	$131
Kowa Pharmaceuticals America, Inc.	9	$118
Bayer	6	$116
Merck	8	$115
Sanofi-aventis U.S. LLC	5	$90
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$81
Exact Sciences	3	$67
Boston Scientific	3	$55
Abbott	3	$54
Biohaven Pharmaceuticals, Inc.	3	$50
Biohaven Pharmaceutical Holding Company Ltd.	3	$46
Nestle Healthcare Nutrition Inc.	3	$44
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$43
Medtronic	2	$37
Edwards Lifesciences	1	$29
E.r. Squibb & Sons, L.L.C.	2	$28
Azurity Pharmaceuticals, Inc.	1	$27
Shield Therapeutics Inc	1	$24
Scilex Pharmaceuticals Inc.	1	$24
Melinta Therapeutics, LLC	1	$23
Sanofi Pasteur Inc.	1	$19
Krystal Biotech Inc	1	$18
Alk-abello, Inc	1	$17
Viatris Specialty LLC	1	$17
Actelion Pharmaceuticals US, Inc.	1	$16
Validus Pharmaceuticals LLC	1	$15
Mylan Specialty L.p.	1	$15
Medicure Pharma Inc.	1	$10

How this compares

$220,367 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan →

Medicare billing

Part B allowed, 2024

$347,793

Medicare patients

585

Services billed

6,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Sterling Heights

Stuart StollerSterling Heights$141K
Steven MargolisSterling Heights$91K
Derrick WilliamsonSouthfield$9.9M
Rebecca RivardRoseville$7M
Paul BensonBerkley$4.2M
Michael HafranEast Lansing$2.7M
Mitzie HewittBuckley$1.3M
Loren ChudlerSouthfield$1.3M
Solomon AmsterWhite Lake$981K
Matt RosenbergJackson$559K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →